Back To: Home : Featured Technology : Functional Genomic Screening

CLICK HERE FOR WHAT'S NEW IN:
 

SeqWright invests in LaserGenís novel reversible terminator chemistry
May 2009
SHARING OPTIONS:

HOUSTONóSeqWright Inc., a commercial provider of genomic analysis and molecular biology services, will make an undisclosed equity investment in LaserGen Inc., a DNA sequencing technology company, the parties announced in April.
 
The decision followed LaserGen's recently revealed plans to commercialize its novel reversible terminator chemistry, Lightning Terminators, for next-generation sequencing applications.
 
SeqWright's investment and next-generation sequencing expertise are expected to facilitate LaserGen's goal of bringing its chemistry as reagent kits to the market as early as 2010 by forming strategic partnerships with existing next-generation instrument manufacturers. Financial terms of the transaction were not disclosed.
 

Back


PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.